1. Home
  2. RTO vs SNN Comparison

RTO vs SNN Comparison

Compare RTO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

HOLD

Current Price

$29.91

Market Cap

16.6B

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$30.48

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RTO
SNN
Founded
1925
1856
Country
United Kingdom
United Kingdom
Employees
64084
16988
Industry
Business Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6B
14.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RTO
SNN
Price
$29.91
$30.48
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$35.00
$36.25
AVG Volume (30 Days)
862.3K
1.3M
Earning Date
03-09-2026
03-16-2026
Dividend Yield
1.60%
2.48%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.05
$8.58
Revenue Next Year
$4.35
$5.60
P/E Ratio
$222.16
$64.97
Revenue Growth
N/A
N/A
52 Week Low
$22.72
$28.56
52 Week High
$34.67
$38.79

Technical Indicators

Market Signals
Indicator
RTO
SNN
Relative Strength Index (RSI) 51.28 52.99
Support Level $29.27 $29.19
Resistance Level $30.15 $31.06
Average True Range (ATR) 0.49 0.55
MACD 0.19 0.03
Stochastic Oscillator 64.60 87.42

Price Performance

Historical Comparison
RTO
SNN

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: